Carvedilol Tablet, Film Coated
NDC Package 51655-034-83
Package Information
Carvedilol tablets is carvedilol is used to treat high blood pressure and heart failure. This formulation utilizes a tablet, film coated delivery system. Marketed by Northwind Health Company, Llc, this product is identified by NDC 51655-034 and is authorized under FDA application ANDA077614.
Identification & Billing
Clinical Specifications
- Adrenergic alpha-Antagonists - [MoA] (Mechanism of Action)
- Adrenergic beta1-Antagonists - [MoA] (Mechanism of Action)
- Adrenergic beta2-Antagonists - [MoA] (Mechanism of Action)
- alpha-Adrenergic Blocker - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Blocker - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 51655 - Northwind Health Company, Llc
- 51655-034 - Carvedilol
- 51655-034-83 - 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
- 51655-034 - Carvedilol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51655-034). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51655-034-83 identifies a specific commercial package of 180 tablet, film coated in 1 bottle, plastic of Carvedilol, a human prescription drug labeled by Northwind Health Company, Llc. This tablet, film coated is formulated for oral use and contains carvedilol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Northwind Health Company, Llc on August 09, 2022. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Carvedilol is used to treat high blood pressure and heart failure. It is also used after a heart attack to improve the chance of survival if your heart is not pumping well. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural substances in your body, such as epinephrine, on the heart and blood vessels. This effect lowers your heart rate, blood pressure, and strain on your heart. Carvedilol belongs to a class of drugs known as alpha and beta blockers.
How is this Northwind Health Company, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51655003483. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.